TOX and neoplasm: Seo et al.37 used a chimeric antigen receptor-engineered T cell (CAR-T) model and found that in PD-1highTIM-3high tumor-infiltrating terminally exhausted CD8+ T cells, both TOX and TOX2 were significantly upregulated.